Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Samrat Pharmachem Ltd-$ (NSE: SAMRATPH), ISIN INE103E01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SAMRATPH last traded at ₹257.90 (-0.02%), with a 52-week range of ₹190.00 to ₹298.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 49.09%, FIIs 3.24%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 65/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.